Immunoglobulins may provide a novel source of drugs for the treatment and suppression of allergic reactions and other immunologically-mediated diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Najjar, V. A. & Fridkin, M. Ann. N.Y. Acad. Sci. 419, 1–272 (1983).
Hahn, G. S. in Protein Abnormalities Vol. 1 (ed. Ritzman, S.E.) 193–304 (Liss, New York, 1982).
Chipens, G. Surv. immun. Res. 4, 220–229 (1985).
Armstrong, R. M., Bray, R. S. & Amstrong, D. L. presentation to the Canadian Neurologic Society International Meeting, June 1985.
Homburger, R. N. Science 189, 389–390 (1975).
Dennis, S. et al. J. Allergy din. Immun. 77, 213 (1986).
Leptin, M. Nature 321, 728 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hahn, G. Immunoglobulin-derived drugs. Nature 324, 283–284 (1986). https://doi.org/10.1038/324283a0
Issue Date:
DOI: https://doi.org/10.1038/324283a0